Entellus Medical, Inc. Announces Pricing of Initial Public Offering (Feb 3, 2015)
PLYMOUTH, Minn., Feb. 3, 2015 (GLOBE NEWSWIRE) — Entellus Medical, Inc. (Nasdaq:ENTL), a medical technology company focused on products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room, announced today the closing of its initial public offering of 5,294,117 shares of its common stock (including 690,537 shares purchased by […]
Entellus Medical, Inc. Announces Pricing of Initial Public Offering (Feb 3, 2015) Read More »